MK0524A

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for MK0524A, covering 2009-05-13 to 2017-04-07. Get the full timeline:

Most recent: Clinical Trial Update: MK0524A Clinical Efficacy Study (0524A-026)(COMPLETED) [Phase 2]